<DOC>
	<DOCNO>NCT00527501</DOCNO>
	<brief_summary>The purpose study compare safety IOP-lowering efficacy fix combination Travoprost/Brinzolamide Ophthalmuc Suspension dose BID QD , TRAVATAN dose QD Vehicle dose BID patient open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>IOP Lowering Efficacy Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension Patients With Open-Angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Brinzolamide</mesh_term>
	<criteria>Patients 18 year age old either sex race diagnose openangle glaucoma confirm ocular hypertension Age ( Under 18 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Open-angle glaucoma</keyword>
	<keyword>ocular hypertension</keyword>
</DOC>